April 13, 2022
Santhera Appoints Shabir Hasham as Chief Medical Officer and Member of the Executive Management Team
Santhera Pharmaceuticals (SIX: SANN) has appointed Shabir Hasham, MD, as Chief Medical Officer (CMO) and a member of Santhera’s Executive Management team, effective May 1, 2022.